GLP Weekly: Liberia’s decisive Ebola response - a blueprint for other pandemics?; Can GMO tobacco produce vaccines for coronavirus and flu?; and more!

GLP Features Articles by GLP staff and contributors

How Liberia’s decisive response to contain the Ebola outbreak provides a blueprint for how to manage the coronavirus and future pandemics Emmanuel Zoboi Gokpolu Can GMO tobacco plants produce vaccines for the coronavirus, flu and ebola? Kostas Vavitsas Our food has never been safer, so why are we so scared of it? Jack Bobo What comic book super heroes and villains tell us about plant and human gene editing – and the coronavirus Fred Roeder Podcast: Coronavirus ‘antidote’ from recovered patient blood? Did the virus escape from a lab? Anti-science activism causes needless harm Cameron English, Kevin Folta Will CRISPR spawn a new wave of crop biotech innovation despite regulatory hurdles? Nina Fedoroff Next-generation gene-editing technology: Path to a second Green Revolution? Nina Fedoroff Are vaccines immunity ‘silver bullets’ to protect us against COVID-19? It depends on how quickly the coronavirus mutates. Sam Moxon Low-hanging fruit: How the first generation of GMO crops yielded massive economic and environmental benefits Nina Fedoroff ‘Public Panic Pandemic’: How our reaction to the coronavirus makes things worse than they should be Ben Locwin